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Misfolding and aggregation of normally 
soluble proteins into amyloid fibrils and their 
deposition and accumulation underlies a 
variety of clinically significant diseases.  
Fibrillar aggregates with amyloid-like 
properties can also be generated in vitro from 
pure proteins and peptides, including those not 
known to be associated with amyloidosis.  
Whilst biophysical studies of amyloid-like 
fibrils formed in vitro have provided important 
insights into the molecular mechanisms of 
amyloid generation and the structural 
properties of the fibrils formed, amyloidogenic 
proteins are typically exposed to mild or more 
extreme denaturing conditions in order to 
induce rapid fibril formation in vitro.  Whether 
the structure of the resulting assemblies is 
representative of their natural in vivo 
counterparts thus remains a fundamental 
unresolved issue.  Here we show using Fourier 
transform infrared spectroscopy, that amyloid-
like fibrils formed in vitro from natively folded 
or unfolded β2-microglobulin, the protein 
associated with dialysis-related amyloidosis, 
adopt an identical β-sheet architecture.  The 
same β-strand signature is observed whether 
fibril formation in vitro occurs spontaneously or 
from seeded reactions.  Comparison of these 
spectra with those of amyloid fibrils extracted 
from patients with dialysis-related amyloidosis 
revealed an identical amide I' absorbance 
maximum, suggestive of a characteristic and 
conserved amyloid fold.  Our results endorse 
the relevance of biophysical studies for the 
investigation of the molecular mechanisms of 
β2-microglobulin fibrillogenesis, knowledge 
about which may inform understanding of the 
pathobiology of this protein. 
Tissue deposition of amyloid fibrils, the 
principal component of amyloid deposits, and their 
persistence in vivo underlies a range of diseases 
known collectively as the amyloidoses (1). 
Amyloid deposits also universally contain 
sulphated glycosaminoglycans (GAGs) and the 
normal plasma glycoprotein serum amyloid P 
component (SAP), which may contribute to 
fibrillogenesis (2), stability (3) and persistence of 
amyloid (1).  A striking feature of natural amyloid 
fibrils, and amyloid-like fibrils generated in vitro, 
is their shared global structural and morphological 
properties, suggesting a common underlying core 
conformation despite the differences in structure 
and function of the many unrelated precursor 
proteins from which they are derived.  Thus, 
amyloid fibrils are characteristically proteinase-
resistant, elongated unbranched fibrils (~10 nm in 
diameter and of indefinite length), composed of 
two or more twisted protofilaments as visualized 
using transmission electron microscopy (TEM).  
They exhibit birefringence that, when stained by 
the dye Congo red under appropriate conditions 
and examined by cross-polarized light microscopy, 
gives rise to transmission of a characteristic bright 
green color, and an X-ray fiber diffraction pattern 
consistent with a cross-β conformation in which 
the polypeptide chain forms β-sheets parallel to 
the fibril long axis with their constituent β-strands 
perpendicular to this axis (1,4).  Furthermore, all 
amyloid fibrils display a generic protein 
conformational epitope recognized by anti-fibril 
antibodies (5) and are bound with high affinity by 
SAP (1,3). Nonetheless, it is clear that 
heterogeneity of the assembly, structure and other 
properties of amyloid fibrils exists, that depends 
on the identity of the fibril precursor protein and 
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the conditions in which fibrillogenesis occurs (6-
11). 
Use of amyloid-like fibrils as tools to 
probe the molecular mechanisms of protein 
misfolding and aggregation has enabled significant 
insights to be made into the ways by which soluble 
proteins assemble into insoluble amyloid fibrils 
(4,12).  Such studies have prompted development 
of different therapeutic strategies to inhibit 
fibrillogenesis (13).  Although such efforts are 
hampered by the lack of high resolution structures 
of amyloid fibrils and their oligomeric 
intermediates, advances in solid state NMR 
spectroscopy and X-ray crystallography are now 
beginning to provide a molecular description of 
the specific and well-ordered packing of the β-
strands within small crystallizable fragments of 
peptides or proteins that form amyloid-like fibrils 
(14,15).  Recent studies have demonstrated the 
apparent ubiquitous ability of polypeptides to form 
amyloid-like fibrils under appropriate conditions, 
commencing from different precursor states, 
dependent on the solution conditions employed 
(16,17).  For example, amyloid-like fibrils with 
similar morphological and dye-binding properties 
are formed from lysozyme at low pH and high 
temperature (18), after proteolysis (19) and 
disulphide bond reduction (20), or in the presence 
of denaturants such as guanidinium chloride 
(GuHCl) (21) or ethanol (22).  However, the 
detailed architecture of these fibrils remains 
unknown.  Studies on protein fragments of 
apolipoprotein A1 have indicated large structural 
differences between amyloid-like aggregates 
formed in vitro and ex vivo amyloid fibrils formed 
from the full-length precursor protein (23).  Thus, 
while amyloid-like fibrils are useful tools for 
biophysical investigations of amyloid formation, 
how closely the fibrils that are induced to form 
rapidly under denaturing conditions resemble 
fibrils formed from natively folded proteins under 
physiological conditions remains an open 
question. Furthermore, how closely fibrils 
generated under artificial conditions in vitro 
resemble genuine amyloid fibrils formed in vivo 
also remains unresolved. 
Here we have used β2-microglobulin 
(β2m), a member of the immunoglobulin 
superfamily with a β-sandwich structure, as a 
model system with which to address these 
questions.  Deposition of β2m amyloid fibrils 
in vivo, predominantly in osteoarticular sites, is 
associated with dialysis-related amyloidosis 
(DRA), a complication of long-term dialysis for 
end stage renal failure (24).  Amyloid-like fibrils 
generated in vitro from pure recombinant β2m in 
seeded or unseeded reactions, commencing from 
denatured or natively folded protein were 
examined using Fourier transform infrared (FTIR) 
spectroscopy and compared with spectra of natural 
β2m amyloid fibrils isolated from a patient with 
DRA.  FTIR provides a powerful means of 
comparing the structural properties of protein 
aggregates since it is not only sensitive to the 
secondary structural composition of proteins, but 
the length and twist of the constituent β-strands 
also influence the resulting absorbance bands (25).  
Our results indicate that amyloid-like fibrils 
formed in vitro from distinct precursor 
conformations of β2m and under different 
assembly conditions adopt an indistinguishable β-
sheet architecture, which is closely similar to that 
found in ex vivo amyloid fibrils, highlighting a 
common amyloid fold, at least for fibrils formed 
from this protein. 
 
EXPERIMENTAL PROCEDURES 
 
Recombinant Proteins.  Full length wild-
type β2m and a double-mutant containing the 
amino acid substitutions Pro32Gly and Ile7Ala 
(P32G/I7A), were expressed in E.coli and purified 
as described previously (7,26). The correct 
molecular mass of the resulting purified proteins 
was confirmed by electrospray ionization mass 
spectrometry (27). Protein stock solutions were 
freshly prepared from lyophilized β2m and filtered 
(0.2 μm, Minisart, Sartorius) before use. 
Nuclear Magnetic Resonance (NMR) 
spectroscopy.  One dimensional (1D) 1H NMR 
spectra were obtained using 84 µM protein in 
25 mM sodium phosphate, 25 mM sodium acetate 
at pH 2.5 (pH 2.5 buffer) or 10 mM sodium 
phosphate at pH 7.0 (pH 7.0 buffer), containing 
90% (v/v) H2O and 10% (v/v) D2O.  Under these 
conditions in the absence of agitation fibril growth 
is very slow, allowing analysis of the structural 
properties of the protein monomer under fibril-
growth conditions.  Spectra were recorded at 37°C 
on a Varian Inova 500 MHz spectrometer using 
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512 transients and processed using the NMRPipe 
suite of programs (28). 
Equilibrium Denaturation.  Tryptophan 
fluorescence of β2m samples was recorded at 37°C 
using 4.2 µM β2m in pH 2.5 or pH 7.0 buffer 
containing increasing concentrations of GuHCl.  
All samples were incubated for 1 h at 37°C prior 
to data acquisition. Fluorescence measurements 
were performed using a Photon Technology 
International (PTI) C-61 spectrofluorimeter with 
excitation at 295 nm and emission at 340 nm using 
4 nm slit widths.  The data were fitted using a two-
state equilibrium model (29) and are represented 
as fractional occupancy of the native state 
(fraction native) at each denaturant concentration. 
Fibril Formation and Characterization.  
Fibrillogenesis in vitro was conducted in 1.5 ml 
Eppendorf tubes.  Pure β2m (84 µM) was 
incubated in either pH 2.5 or pH 7.0 buffer, 
containing 0.05% (w/v) NaN3, at 37°C with 
agitation (250 rpm) for varying periods of time.  
Control experiments demonstrated that altering the 
type or speed of agitation affected the rate, but not 
the morphology, of the fibrils formed.  For 
selected experiments, seeds were prepared from 
fibrils grown for 14 days at pH 2.5 from wild-type 
β2m that were stabilized against depolymerization 
at pH 7.0 by addition of the sulphated GAG 
heparin (porcine, average mass 5kDa, Sigma-
Aldrich) (2), after which they were fragmented by 
freeze-thaw cycling (2) and stored at -20°C.  For 
seeded growth experiments, seeds were added to a 
final concentration of 5% (w/w) of total β2m.  
Fibril formation was monitored by the enhanced 
fluorescence intensity of Thioflavin-T (ThT) that 
occurs upon interaction of the dye with amyloid 
fibrils (30).  Aliquots (10 μl) of the suspensions 
were withdrawn at specific times after initiation of 
fibrillogenesis, diluted 100-fold into freshly 
prepared 0.5 M Tris-HCl buffer pH 8.5 containing 
10 µM ThT, and the fluorescence emission at 
480 nm (4 nm slit width) was measured using a 
PTI C-61 spectrofluorimeter after excitation at 
444 nm (4 nm slit width).  Data were highly 
reproducible (within ± 10%) and the average of 
triplicate readings for each sample was normalized 
to that of ThT in the starting buffer alone.  
Aggregates of β2m were also prepared by 
incubating β2m (84 µM) at (i) 37°C in 25 mM 
sodium phosphate, 25 mM sodium acetate buffer 
at pH 3.6 containing 200 mM NaCl and 0.05% 
(w/v) NaN3 for 3 days without agitation to produce 
short (<500 nm) fibrils with a worm-like 
morphology (8), or (ii) 60°C in 10 mM sodium 
phosphate pH 5.0 for 1 hour to yield amorphous 
aggregates.  β2m amyloid fibrils were isolated by 
water extraction, after removal of endogenous 
SAP (31), from unfixed frozen (-80°C) 
amyloidotic shoulder synovial tissue of a British 
patient with DRA obtained with written consent 
(Helsinki Declaration) and ethical approval (Ethics 
Committee, Royal Free Hampstead NHS Trust, 
London).  Fractions containing the highest 
concentration of the ex vivo fibrils were pooled, 
and purity examined by reducing SDS PAGE 
using 15% homogeneous gels (31).  The fibrils 
were characterized also by mass spectrometry and 
protein sequencing as described elsewhere (32).  
All fibrils were stored after preparation at 4°C in 
the presence of 0.05-0.1% (w/v) NaN3, and their 
amyloid-like characteristics examined by TEM 
after negative staining (7), cross-polarized light 
microscopy after staining with alkaline alcoholic 
Congo red (31) and binding by 125I-labelled SAP 
(125I-SAP) (2,3). 
Thin Film Attenuated Total Reflectance 
Fourier Transform Infrared (TF-ATR-FTIR) 
Spectroscopy.  Lyophilized monomeric β2m was 
dissolved directly in D2O at the appropriate pD to 
a concentration of ~0.4 mM.  β2m fibrils, prepared 
as described above, were centrifuged (20 min at 
13,000 rpm) to remove any soluble material and 
the pellets washed once in D2O before 
resuspension in D2O at the appropriate pD to a 
concentration of ~0.4 mM (2).  Aliquots (~150 µl) 
of monomeric β2m or fibrils were spread onto the 
surface of a germanium crystal ATR plate and 
excess water evaporated using a current of N2 gas 
to form a hydrated thin protein film ideal for 
analysis of such samples (33,34).  The presence of 
residual solvent in the film was apparent from the 
absorbance band of D2O at ~1210 cm-1.  Control 
experiments demonstrated that the spectra 
obtained were not affected by the extent of solvent 
evaporation.  After purging the system with dry air 
for 15 min to remove water vapor, FTIR 
absorbance spectra were recorded at room 
temperature 2 h after suspension in D2O, using a 
Thermo-Nicolet 560 FTIR spectrometer.  For each 
sample, 1024 scans were accumulated at a spectral 
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resolution of 2 cm-1.  Spectra acquired of the 
background (ATR plate without protein sample) 
were subtracted from those of the samples before 
curve fitting the amide I' region (1700-1600 cm-1).  
Second derivative and Fourier self-deconvoluted 
spectra (employing a resolution enhancement 
factor of ~1.6 and a bandwidth of ~16 cm-1) were 
used to identify peak maxima.  Using this 
information, the raw spectra were then fitted to a 
series of Gaussian peaks with the identified 
absorbance maxima using an iterative curve-fitting 
procedure performed in SigmaPlot (Systat 
Software Inc.).  The position of individual peaks 
was held fixed while the bandwidth (assumed to 
be identical for all peaks) was allowed to globally 
vary between 10 and 20 cm-1 during the fit.  The 
band assignments as well as the resulting 
calculated FTIR spectra (33) upon solution 
convergence to a minimum are shown.  The amide 
I' band with the highest intensity is defined as the 
amide I' maximum throughout the manuscript.  
Replicate experiments commencing with new 
preparations of monomer, demonstrated both the 
reproducibility of fibrillogenesis and the FTIR 
analysis. 
 
RESULTS 
 
Different precursors facilitate fibril 
formation of β2m.  The formation of amyloid-like 
fibrils in vitro from wild-type β2m has been 
extensively studied over a number of years, the 
results demonstrating that fibrils with a cross-β 
structure displaying all of the hallmarks of 
amyloid are generated rapidly (within hours) and 
spontaneously when β2m is incubated at pH 2.5 in 
low ionic strength (<50 mM) buffer (8,26,35).  It 
has been shown previously that under these 
conditions monomeric β2m is highly unfolded: the 
protein no longer retains β-sheet structure and 
specific side-chain contacts are also absent in this 
highly dynamic ensemble (36,37).  Accordingly as 
shown here by 1D 1H NMR, the spectrum of acid 
unfolded β2m contains sharp resonances with little 
chemical shift dispersion (Fig. 1A) consistent with 
an unfolded state.  Under these conditions the 
protein does not display a cooperative unfolding 
transition when incubated with increasing 
concentrations of GuHCl, a feature also 
characteristic of a highly unfolded state (Fig. 1B).  
At pH 2.5 fibril formation proceeds with 
nucleation-dependent polymerization kinetics 
(7,35), typified by an initial lag-phase during 
which small oligomeric species are formed (38), 
prior to rapid fibril growth reflected by a 
substantial (~120-fold) increase in ThT 
fluorescence (Fig. 1C).  At the endpoint of 
incubation, amorphous aggregates are not visible 
by TEM (Fig. 1F) and the suspension consists 
predominantly of fibrils (more than 95% yield) 
that are ~12 nm in diameter and have a long, 
straight morphology with a characteristic helical 
twist (7). 
By contrast with the behavior of acid 
unfolded β2m, incubation of β2m in its native state 
in low ionic strength buffer at neutral pH does not 
result in an increase in ThT fluorescence (Fig. 1D 
grey circles) and fibrils are not observed even after 
incubation for months at 37°C (2,39,40).  Instead, 
the protein retains its native structure as 
demonstrated by the well-dispersed resonances in 
the 1D 1H NMR spectrum of this state (Fig. 1A) 
and its cooperative unfolding transition when 
incubated with GuHCl (Fig. 1B). 
To generate fibrils from native β2m at 
neutral pH, a procedure was employed in which 
fibrils formed by spontaneous (unseeded) growth 
at pH 2.5 were first stabilized by the addition of 
low molecular weight heparin (see Experimental 
Procedures).  These fibrils were subsequently 
fragmented and used to seed fibril growth from the 
native wild-type protein (2).  Consistent with 
previous results (2) the addition of these so-called 
heparin-stabilized seeds to monomeric β2m at pH 
7.0 abolished the lag-phase and resulted in a small, 
but significant (~18-fold) increase in ThT 
fluorescence after incubation for 14 days 
(Fig. 1D).  At the end-point of this incubation, 
fibrils that are morphologically indistinguishable 
from those produced spontaneously from the 
acid-unfolded protein were formed (Fig. 1G). 
In order to form amyloid-like fibrils from 
native β2m at neutral pH in the absence of 
additives or seeds, new variants of the protein 
were created, building on our previous 
observations that single amino acid substitutions in 
the N- or C-terminal regions of the polypeptide 
chain confer enhanced amyloidogenic potential at 
neutral pH, as does the variant in which the single 
cis Pro32 is replaced with trans Gly (40,41).  
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Accordingly, the double-mutant P32G/I7A was 
selected for further analysis.  At 37°C at neutral 
pH, P32G/I7A β2m is natively folded as judged by 
the linewidth and chemical shift dispersion of its 
1D 1H NMR spectrum, but is significantly 
destabilized compared with wild-type β2m (ΔΔGun 
= 14 kJ mol-1) (Fig. 1A and B).  Importantly, 
P32G/I7A is able to self-assemble in a nucleation-
dependent manner to produce amyloid-like fibrils 
without the need for denaturant, heparin, other 
additives or seeds, that give rise to a moderately 
(~30-fold) enhanced ThT fluorescence signal 
(Fig. 1E).  TEM reveals abundant fibrils ~12 nm in 
diameter that morphologically resemble those 
generated de novo from acid-unfolded wild-type 
β2m and by seeded growth of native β2m at pH 7.0 
(Fig. 1F and H). 
The amyloid-like nature of the fibrils 
produced in vitro using each of these conditions 
was confirmed by their ability to bind Congo red 
under selective staining conditions and produce 
green birefringence when viewed in cross-
polarized light microscopy. In addition, each of 
the fibril types displayed specific, concentration-
dependent binding by 125I-SAP and gave rise to a 
classical cross-β diffraction pattern after 
examination by X-ray fiber diffraction ((2) and 
results not shown) confirming their identity as 
genuine amyloid.  Using these protein variants and 
incubation conditions, therefore, amyloid-like 
fibrils can be produced from acid unfolded β2m, as 
well as from the native protein in seeded and 
unseeded reactions at pH 7.0, allowing a direct 
comparison of the fibrils formed by different 
mechanisms, under different assembly conditions, 
and from highly distinct initial precursor 
conformations. 
 The β2m amyloid fold is precursor-
independent.  To determine the similarity in the 
content and organization of secondary structure in 
each of the fibril samples formed from β2m under 
different conditions, the fibrils and their precursors 
were examined by ATR-FTIR spectroscopy 
(Fig. 2).  This technique can distinguish between 
the ordered β-sheet conformations in native 
proteins and insoluble ones such as amyloid fibrils 
(25).  The amide I' band which absorbs between 
the wavelengths 1600 and 1700 cm-1 is a widely 
used and sensitive probe for characterizing the 
secondary structure components of proteins 
(42,43).  The FTIR spectra of acid unfolded and 
native β2m are highly distinct (Fig. 2A-C).  The 
spectrum of the acid unfolded protein at pH 2.5 
contains a broad amide I' peak with an absorbance 
maximum, determined by second derivative and 
Fourier self-deconvoluted spectra (see 
Experimental Procedures), of 1648 cm-1 (Fig. 2A).  
These data are consistent with an unordered 
polypeptide chain, in accord with results obtained 
by 1D 1H NMR and equilibrium denaturation 
(Fig. 1A, B).  The spectrum of wild-type β2m in its 
native conformation at pH 7.0 differs markedly 
from that of the unfolded state, showing a 
relatively narrow amide I' absorbance maximum at 
1634 cm-1 (Fig. 2B), characteristic of a folded 
immunoglobulin domain (44).  The spectrum of 
P32G/I7A β2m is indistinguishable from that of 
native wild-type β2m (Fig. 2C) indicating that 
despite being significantly destabilized, this 
variant also adopts a native immunoglobulin fold 
at neutral pH, consistent with the 1H-NMR 
spectrum of this protein (Fig. 1A). 
FTIR spectra of the amyloid-like fibrils of 
β2m formed under the three different conditions 
studied are shown in Fig. 2D-F.  Strikingly, and by 
contrast with the very different FTIR spectra of 
their native and denatured monomeric precursors, 
the FTIR spectra of all three amyloid-like fibrils 
are identical, each showing a distinct absorbance 
maximum at 1632 cm-1, suggesting that they 
possess a common β-sheet architecture.  Analysis 
of the difference spectra between each monomeric 
precursor and its correspondent fibrillar species 
reveals distinct structural transitions upon fibril 
formation (Fig. 2G-I).  A large shift in the 
absorbance maximum is observed upon fibril 
formation at pH 2.5 (Fig. 2G), consistent with the 
generation of β-sheet structure from the highly 
unfolded monomeric precursor.  By contrast, only 
a small shift in the absorbance maximum (from 
1634 to 1632 cm-1) occurs when fibrils are formed 
from the native protein at neutral pH using either 
seeded or unseeded growth (Fig. 2H and I).  The 
identity of the FTIR spectra of the fibrils formed 
in vitro from different precursors is remarkable 
given the high sensitivity of FTIR spectroscopy to 
the length and twist of β-strands, as well as the 
number of β-strands per sheet (25), and 
considering the very different growth conditions, 
assembly mechanisms (nucleated and templated 
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growth) and timescales of fibril formation (hours 
to weeks) of each sample. 
As a further demonstration of the 
sensitivity of FTIR spectroscopy to the 
conformational state of β2m, different aggregated 
states of the wild-type protein were generated and 
the resulting spectra compared with those obtained 
for β2m amyloid-like fibrils.  Thus, 'worm-like' 
fibrils formed by the assembly of partially folded 
monomers at pH 3.6 (8), and amorphous 
aggregates formed by heating the protein to 60°C 
close to its pI (see Experimental Procedures) were 
generated (Fig. 3).  Although the worm-like fibrils 
have been shown previously to bind ThT and give 
rise to an X-ray fiber diffraction pattern consistent 
with a cross-β structure, they do not exhibit clear 
green birefringence after staining by Congo red 
and display reactivity to anti-amyloid antibodies 
distinct from the long straight amyloid-like fibrils 
analyzed here, suggesting that their structure is 
distinct from that typical of amyloid (8,26).  
Importantly, the worm-like fibrils and amorphous 
aggregates give rise to FTIR spectra with amide I' 
absorbance maxima at different frequencies from 
those of the amyloid-like fibrils of β2m (Fig. 3B 
and C), confirming that the amide I' maximum at 
1632 cm-1 is specific and characteristic of the 
cross-β structure of β2m amyloid. 
 The structure of amyloid-like fibrils of β2m 
generated in vitro resembles their ex vivo 
counterparts. To determine how closely β2m 
amyloid-like fibrils resemble their natural in vivo 
counterparts, amyloid fibrils were isolated under 
non-denaturing conditions and without additional 
purification from the tissue of a patient with DRA.  
These fibrils appear in negative stain TEM as 
predominantly dense aggregates in which adjacent 
fibrils are often intertwined and interconnected 
(Fig. 4A), a feature typical of ex vivo amyloid 
fibril preparations (31).  SDS-PAGE analysis 
(Fig. 4B) revealed that the fibrils consisted 
predominantly of proteins that migrated as a 
~12 kDa doublet, and which corresponded, as 
identified by proteomics and described elsewhere 
(32), to intact full-length β2m (~75% abundance) 
and a truncated species (~25% abundance) lacking 
the N-terminal 6 amino acids which is consistently 
found in ex vivo β2m fibril isolates (32,45,46).  
FTIR spectroscopy of the ex vivo fibrils enabled a 
detailed comparison of the structural properties of 
the β-sheets of natural amyloid with their in vitro 
counterparts.  Importantly, the FTIR spectrum of 
ex vivo β2m amyloid exhibits an amide I' 
maximum at 1632 cm-1 (Fig. 4C), precisely as 
observed for amyloid-like fibrils formed in vitro 
by wild-type β2m (Fig. 2D and E) and the variant 
P32G/I7A (Fig. 2F and Fig. 4D).  Although the 
ex vivo preparation consists predominantly of 
amyloid fibrils, it may also contain traces of co-
isolated lipids, glycans, non-fibrillar extracellular 
matrix proteins and possibly also unfolded 
proteins resulting from the extraction procedure, 
the latter of which may give rise to the increased 
intensity of the 1648 cm-1 band observed in its 
FTIR spectrum (Fig. 2A).  Alternatively, the 
increased intensity of this band could reflect 
differences in the structure of non β-sheet 
components of the fibrils formed in vivo compared 
with those generated in vitro.  Despite these minor 
differences, the distinct amide I' maximum at 
1632 cm-1 for all β2m amyloid samples examined 
here demonstrates, for the first time, the structural 
similarity in the β-sheet architecture of amyloid-
like fibrils formed in vitro from pure recombinant 
β2m and their in vivo counterparts (Fig. 4D and E). 
 
DISCUSSION 
 
In this study, we have exploited the 
sensitivity of FTIR spectroscopy to the secondary 
structural content, as well as the length and twist 
of β-strands in soluble and insoluble proteins 
(25,47), to demonstrate the similarity in β-sheet 
structure of amyloid-like fibrils generated from 
β2m in vitro under an array of different conditions 
with their ex vivo counterparts.  Whilst subtle 
differences in the fibril architecture, for example 
in the precise stacking of the β-strands, the 
organization of non-β-sheet components and the 
arrangement of the side chains, cannot be 
discerned by FTIR spectroscopy and would 
require more detailed elucidation, for example, by 
solid state NMR spectroscopy (48), the ability of 
FTIR spectroscopy to distinguish the structures of 
long straight versus worm-like β2m fibrils and 
different types of aggregates (amyloid-like fibrils 
versus amorphous aggregates) supports the 
concept of a common β-sheet organization for the 
β2m amyloid fibrils studied here.  These results are 
consistent with previous findings whereby limited 
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proteolysis revealed a common structural core of 
ex vivo and in vitro β2m amyloid involving 
residues ~10-99 (27,49,50). 
The structural similarity between 
amyloid fibrils formed from different precursor 
states of β2m under different growth conditions 
has several implications.  Firstly, the FTIR amide 
I' absorbance maximum of β2m amyloid fibrils at 
1632 cm-1 is highly distinct compared with the 
FTIR absorbance maxima of amyloid-like fibrils 
generated in vitro from other proteins and peptides 
that typically yield a maximum below 1625 cm-1 
(25) (Fig. 5 and Supplementary Information).  As 
noted by Fändrich and colleagues (25) and shown 
here in Fig. 5, a clear difference is observed in the 
frequency distribution of the amide I' absorbance 
maxima of native β-sheet proteins and that of 
amyloid-like fibrils, consistent with significant 
differences in the twist and/or length of their 
constituent β-sheets.  Interestingly, while the FTIR 
absorbance maximum of native β2m monomers 
lies within the expected range for native β-sheet 
proteins, β2m amyloid-like fibrils exhibit an amide 
I' maximum at the edge of the range reported to 
date for amyloid-like fibrils formed in vitro from 
many other different proteins (Fig. 5). While a 
higher frequency at 1632 cm-1, obtained by 
synchrotron FTIR microspectroscopy of Aβ 
amyloid deposits in situ in sections of brain tissue 
of patients with Alzheimer’s disease, was 
previously attributed to the non-fibrillar 
components of amyloid (51), such an explanation 
can be ruled out for the β2m fibrils examined here 
based on their purity, high yield and the fact that 
the amide I' absorbance maximum does not change 
upon limited proteolysis (GW Platt and SER, 
unpublished results). Our results here indicate, 
therefore, an amide I' absorbance maximum for 
β2m amyloid that is highly distinct from that 
(1618 cm-1) suggested to be typical for other 
amyloid-like fibrils (52). 
The finding that an amyloid fold with a 
common β-sheet architecture results from the 
incubation of β2m under a wide range of 
conditions, including different growth rates; in 
seeded and unseeded reactions; from precursors 
with very different initial conformations; and in 
the absence or presence of additional biological 
factors, suggests that the aggregation free energy 
landscape of β2m possesses a distinct global 
minimum that can be accessed readily irrespective 
of the conditions employed (53,54).  This result 
contrasts markedly with amyloid-like fibrils 
formed from the human prion protein, for 
example, wherein different protein sequences and 
seeding conditions result in amyloid-like fibrils 
with different structural properties resolvable by 
FTIR spectroscopy (55,56).  Establishing the 
underlying shape of the aggregation free energy 
landscape for different protein sequences and how 
this responds to changes in the growth conditions, 
therefore, will be needed to determine the full 
repertoire of amyloid structures (15,57) and to 
reveal how the aggregation landscapes lead to 
functional amyloid or amyloid assembly routes 
and protein depositions associated with disease 
(54,58). 
Finally, our results provide the first direct 
evidence that the organization of β-sheets in β2m 
amyloid-like fibrils formed in vitro in a highly 
acidic environment, as well as at neutral pH, is 
indistinguishable from that of fibrils formed from 
the same protein in vivo under pathophysiological 
conditions, at least as determined by FTIR 
spectroscopy.  This study therefore validates 
structural and mechanistic analyses of 
fibrillogenesis in vitro to provide insights into the 
formation of β2m amyloid fibrils and their 
pathological consequences and confirm the 
validity of these amyloid-like fibrils as mimics of 
natural β2m amyloid fibrils.  Interestingly, a recent 
analysis of Aβ42 fibrils formed on a synthetic 
surface containing immobilized Aβ42 oligomers 
in the presence of Fe3+ also resulted in an FTIR 
spectrum with an absorbance maximum at 
1632 cm-1, identical to that observed here for 
amyloid fibrils of β2m (59).  Further comparative 
studies of amyloid-like fibrils derived in vitro 
from amyloidogenic precursor proteins associated 
with other types of amyloidosis and their in vivo 
counterparts will now be needed to determine 
whether the FTIR amide I' absorbance maximum 
at 1632 cm-1 is a feature shared by amyloid-like 
fibrils and genuine amyloid fibrils of other 
chemical types.   
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FOOTNOTES 
 
The abbreviations used are: ATR, attenuated total reflectance; β2m, β2-microglobulin; DRA, dialysis-
related amyloidosis; FTIR, Fourier transform infrared; GAGs, glycosaminoglycans; NMR, nuclear 
magnetic resonance; SAP, serum amyloid P component; TEM, transmission electron microscopy. 
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FIGURE LEGENDS 
 
Figure 1.  Analysis of the structure and stability of different monomeric β2m precursors and the 
resulting amyloid-like fibrils from which they were derived.  (A) 1D 1H NMR spectra and (B) 
equilibrium denaturation curves of monomeric wild-type β2m at pH 2.5 (red) and pH 7.0 (black) and 
P32G/I7A β2m at pH 7.0 (blue) at 37 °C.  (C-E) Fibrillogenesis monitored by ThT fluorescence.  (C) 
Unseeded fibril formation of wild-type β2m at pH 2.5.  (D) Unseeded (gray circles) and seeded growth 
(black circles) of fibrils of wild-type β2m at pH 7.0.  Fragmented fibrils from (C) stabilized by the 
presence of heparin were used as seeds (see Experimental Procedures).  (E) Amyloid-like fibril formation 
of P32G/I7A β2m at pH 7.0 in the absence of added seeds.  (F-H) Representative negative stain TEM 
images of amyloid-like fibrils formed from wild-type β2m at pH 2.5 (F) and at pH 7.0 upon addition of 
seeds (G), and from P32G/I7A β2m in unseeded growth at pH 7.0 (H).  Scale bars represent 100 nm. 
 
Figure 2.  Analysis of the secondary structure of monomeric and fibrillar β2m by ATR-FTIR 
spectroscopy.  FTIR spectra of the amide I' region of deuterated monomeric (A-C) and fibrillar (D-F) 
β2m (solid black lines) showing the component bands (grey lines).  (G-I) Difference spectra illustrating 
the structural changes between monomeric and fibrillar species for each growth condition.  (A, D, G) 
Wild-type β2m at pH 2.5 (unseeded growth), (B, E, H) wild-type β2m at pH 7.0 (seeded growth), and (C, 
F, I) P32G/I7A β2m at pH 7.0 (unseeded growth).  In A-F, the sum (black dashed lines) of individual 
spectral components (gray lines) after Fourier self-deconvolution, closely matches the experimental data 
(solid black lines). 
 
Figure 3.  Comparison of ATR-FTIR spectra from different β2m aggregates.  (A) Overlay FTIR 
spectra of amyloid-like fibrils formed in vitro from wild-type β2m at pH 2.5 (dotted line) and P32G/I7A 
β2m fibrils formed at pH 7.0 (solid line), indicating their common amide I' absorbance maximum at 
1632 cm-1.  The difference spectrum is shown below.  FTIR spectra (B, D) and TEM analyses (C, E) of 
non-amyloid short fibrils with a worm-like morphology formed by wild-type β2m at pH 3.6 (B, C) and 
amorphous non-amyloid aggregates formed by heating wild-type β2m to 60ºC at pH 5.0 (D, E).  
Difference spectra of each aggregate type compared with amyloid-like fibrils formed from wild-type β2m 
at pH 2.5 are shown below each spectrum.  Scale bars in C and E represent 200 nm. 
 
Figure 4.  Analysis of ex vivo β2m amyloid fibrils.  (A) Negative stain TEM micrograph of ex vivo β2m 
amyloid fibrils (scale bar represents 200 nm).  (B) Reduced denatured SDS-PAGE stained with Brilliant 
blue R-350, of pure recombinant wild-type β2m (lane 2) and isolated pooled ex vivo β2m amyloid fibrils 
(lane 3).  The relative molecular mass of standard marker proteins (M) is indicated in kDa on the left.  (C) 
Amide I' region of the ATR-FTIR spectrum of ex vivo β2m amyloid fibrils (black lines).  Spectral 
components (gray lines) are shown after deconvolution, with individual band assignments and their sum 
(black dotted line).  (D) Overlay FTIR spectra of amyloid-like fibrils formed in vitro from P32G/I7A β2m 
at pH 7.0 (dotted line) and isolated ex vivo β2m amyloid fibrils (solid line), indicating the common β-sheet 
component at 1632 cm-1.  (E) The FTIR difference spectrum between the fibrils formed from P32G/I7A 
β2m in vitro and the ex vivo amyloid fibrils shown in (D) indicates their close structural identity. 
 
Figure 5.  Comparison of the amide I' absorbance maxima in the ATR-FTIR spectra of different 
native β-sheet proteins and amyloid-like fibrils formed in vitro from various different proteins and 
peptides.  The amide I' maximum of native β-sheet proteins is shown as black bars and that of fibrils is 
shown as gray bars.  This figure updates that published previously by Zandomeneghi et al (25).  A clear 
difference in the frequency distribution of the amide I' absorbance maxima of native β-sheet proteins and 
that of fibrils is observed, indicating differences in their β-sheet architecture.  Importantly, while the 
amide I' absorbance maximum of native β2m (N) falls within the expected range for native β-sheet 
12 
proteins, the amyloid-like fibrils formed from β2m in vitro and in vivo (A) result in an amide I' maximum 
at the edge of the range reported previously for all amyloid-like fibrils reported to date.  Interestingly, this 
band also falls within the distribution of native β-sheet proteins.  The absorbance maximum of acid 
unfolded β2m is also indicated (U).  The proteins used for this analysis are listed in Supplementary Tables 
1 and 2. 
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